Understanding Lipoprotein(a)- Novel Therapeutics to Reduce Lp(a) Levels and Improve Cardiovascular Outcomes

3d human heart  medical anatomy

Program Overview This CME/CNE program will highlight content presented at the European Society of Cardiology (ESC) Congress 2018 in Munich, Germany. The three expert faculty, led by Dr. Patrick M. Moriarty, will assess the role of lipoprotein(a)- novel therapeutics in reducing Lp(a) levels and improving cardiovascular outcomes. A state of the science of lipoprotein(a), including […]

Continue reading


Identifying Financial and/or Treatment Access Barriers: Patient Perspectives

Program Overview In this module of a Four-Part Expert Interview Series, Dr. James A. Underberg, along with Dr Christopher P. Cannon, course chair, will identify barriers to caring for dyslipidemia patients. There barriers will include financial and other patient-related obstacles. This discussion will incorporate strategies to improve access to PCSK9 inhibitors, in turn leading to […]

Continue reading


Further Insights in Lowering LDL Cholesterol: Managing Atherosclerotic Disease in High-Risk Patients

precipitate and narrowing of the blood vessels - arteriosclerosis

Program Overview In this module of a Four-Part Expert Interview Series, Dr. Marc P. Bonaca, along with Dr. Christopher P. Cannon, course chair, will discuss options for lowering LDL cholesterol in dyslipidemia patients. This will include recent outcomes from clinical trials and the diagnostic criteria of peripheral artery disease. Enabling physicians to recognize physical indicators […]

Continue reading